“Capital + Talent = Huge Exit”

How the right CEO and Board Chair create the outcome needed.

NMS Capital had just acquired Clinical Trials of Texas, a founder-led clinical research organization with deep expertise but limited scale. The private equity playbook was clear: roll up CROs to build a national platform.

NMS needed a proven operator who could integrate acquisitions, standardize processes across multiple sites, and build the infrastructure for a strategic exit. They needed someone who had done this before. And they needed a Board Chair who could guide the transformation.

Canopy didn't just look for CRO insiders. We looked for executives who had taken fragmented regional businesses and turned them into integrated platforms.

The Outcome

Genstar Capital acquired that transformation in what industry insiders described as a “whopping exit.” The platform the Canopy candidates built was exactly what a larger PE firm was looking for.